The fixed herbal drug composition "Saikokaryukotsuboreito" prevents bone loss with an association of serum IL-6 reductions in ovariectomized mice model

Phytomedicine

Volumn 17, Issue 3-4, 2010, Pages 170-177

  Hattori, T ^a   Fei, W ^a   Kizawa, T ^a   Nishida, S ^a   Yoshikawa, H ^a   Kishida, Y ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Herbal medicine; IL 6; Osteoporosis; Saikokaryukotsuboreito

Indexed keywords

CHOLESTEROL; ESTRADIOL; INTERLEUKIN 6; SAIKO KA RYUKOTSU BOREI TO;

AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BONE METABOLISM; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; LUMBAR SPINE; MASS SPECTROMETRY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOLYSIS; OVARIECTOMY; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; SHAM PROCEDURE; TIBIA;

ANALYSIS OF VARIANCE; ANGIOSPERMS; ANIMALS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CHOLESTEROL; DIET; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; ESTRADIOL; FEMALE; INTERLEUKIN-6; LUMBAR VERTEBRAE; MICE; MICE, INBRED C57BL; OSTEOPOROSIS; OVARIECTOMY; TIBIA;

MURINAE; MUS;

EID: 75349110209     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.12.004     Document Type: Article

References (42)

1. Barrett-Connor E., Mosca L., Collins P., Geiger M.J., Grady D., Kornitzer M., McNabb M.A., Wenger N.K., and Raloxifene Use for The Heart (RUTH) Trial Investigators. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. The New England Journal of Medicine 13,355 2 (2006) 125-137
2. Bellido T., Jilka R.L., Boyce B.F., Girasole G., Broxmeyer H., Dalrymple S.A., Murray R., and Manolagas S.C. Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens: the role of the androgen receptor. The Journal of Clinical Investigation 95 6 (1995) 2886-2895
3. Chae H.J., Kang J.S., Kim J.H., Kim C.W., Yoo S.K., Shin T.Y., Choi B., Kim H.M., and Kim H.R. Antiosteoporotic activity of Dae-Bo-Won-Chun in ovariectomized rats. Phytotherapy Research 15 1 (2001) 53-57
4. Chen H., Emura S., Isono H., and Shoumura S. Effects of traditional Chinese medicine on bone loss in SAMP6: a murine model for senile osteoporosis. Biological & Pharmaceutical Bulletin 28 5 (2005) 865-869
5. Chung H.J., Maruyama I., and Tani T. Saiko-ka-ryu-kotsu-borei-to inhibits intimal thickening in carotid artery after balloon endothelial denudation in cholesterol-fed rats. Boilogical & Pharmaceutical Bulletin 26 1 (2003) 56-60
6. Cui L., Wu T., Deng Y.Y., Ai C.M., and Chen H.Q. Tanshinone prevents cancellous bone loss induced by ovariectomy in rats. Acta Pharmacologica Sinica 25 5 (2004) 678-684
7. Dang S.S., Wang B.F., Cheng Y.A., Song P., Liu Z.G., and Li Z.F. Inhibitory effects of saikosaponin-d on CCI4-induced hepatic fibrogenesis in rats. World Journal of Gastroenterology 13 4 (2007) 557-563
8. Delmas P.D., Bjarnason N.H., Mitlak B.H., Ravoux A.C., Shah A.S., Huster W.J., Draper M., and Christiansen C. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in pistmenopausal women. The New England Journal of Medicine 4 (1997) 1641-1647
9. Edwards C.J., Hart D.J., and Spector T.D. Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355 9222 (2000) 2218-2219
10. Flanagan A.M., Stow M.D., and Williams R. The effect of inteleukin-6 and soluble interleukin-6 receptor protein on the bone resorptive activity of human osteoclasts generated in vitro. The Journal of Pathology 176 3 (1995) 289-297
11. Han S.Y., Lee J.R., Kwon Y.K., Jo M.J., Park S.J., Kim S.C., Lee H.S., and Ku S.K. Ostreae Testa prevent ovariectomy-induced bone loss in mice by osteoblast activations. Journal of Ethnopharmacology 114 3 (2007) 400-405
12. Hill K. The demography of menopause. Maturitas 23 2 (1996) 113-127
13. Hidaka S., Okamoto Y., Nakajima K., Suekawa M., and Liu S.Y. Preventive effects of traditional Chinese (Kampo) medicines on experimental osteoporosis induced by ovariectomy in rats. Calcified Tissue International 61 3 (1997) 239-246
14. Hidaka S., Okamoto Y., Yamada Y., Kon Y., and Kimura T. A Japanese herbal medicine, Chujo-to, has a benefical effect on osteoporosis in rats. Phytotherapy Research 13 1 (1999) 14-19
15. Hodsman A.B. Fragility fractures in dialysis and transplant patients. Is it osteoporosis, and how should it be treated?. Peritoneal Dialysis International 21 Suppl. 3 (2001) S247-S255
16. Jika R.L., Hangoc G., Girasole G., Passeri G., Williams D.C., Abrams J.S., Boyce B., Broxmeyer H., and Manolagas S.C. Increased osteoclast debelopment after estrogen loss: mediation by interleukin-6. Science 257 5066 (1992) 88-91
17. Kannappan S., Jayaraman T., Rajasekar P., Ravichandran M.K., and Anuradha C.V. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Medical Journal 47 10 (2006) 858-863
18. Ke H.,Z., Chen H.K., Qi H., Pirie C.M., Simmons H.A., Ma Y.F., and Thompson D.D. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats. Bone 17 (1995) 491-496
19. Leung C.Y., Liu L., Wong R.N., Zeng Y.Y., Li M., and Zhou H. Saikosaponin-d inhibits T cell activation through the modulation of PKCtheta, JNK, and NF-kappaB transcription factor. Biochemical and Biophysical Research Communications 338 4 (2005) 1920-1927
20. Li H., Miyahara T., Tezuka Y., Namba T., Nemoto N., Tonami S., Seto H., Tada T., and Kadota S. The effect of Kampo formulae on bone resorption in vitro and in vivo.1. Active constituents of Tsu-kan-gan. Biological Pharmaceutical Bulletin 21 12 (1998) 1322-1326
21. Li H., Miyahara T., Tezuka Y., Namba T., Suzuki T., Dowaki R., Watanabe M., Nemoto N., Tonami S., Seto H., and Kadota S. The effect of Kampo formulae on bone resorption in vitro and in vivo. 2. Detailed study of berberine. Biological & Pharmaceutical Bulletin 22 4 (1999) 391-396
22. Libermann T.A., and Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription Factor. Molecular and Cellular Biology 10 5 (1990) 2327-2334
23. Liu J., Shiono J., Shimizu K., Yu H., Zhang C., Jin F., and Kondo R. 20(R)-ginsenoside Rh2, not 20(S), is a selective osteoclastgenesis inhibitor without any cytotoxicity. Bioorganic & Medical Chemistry Letters 19 12 (2009) 3320-3323
24. Matsuda A., Wang Z., Takahashi S., Tokuda T., Miura N., and Hasegawa J. Upregulation of mRNA of retinoid binding protein and fatty acid binding protein by cholesterol enriched-diet and effect of ginger on lipid metabolism. Life Science 84 25-26 (2009) 903-907
25. Melton III L.J., Kan S.H., Frye M.A., Wahner H.W., O'Fallon W.M., and Riggs B.L. Epidemiology of vertebral fractures in woman. American Journal of Epidemiology 129 5 (1989) 1000-1011
26. Mundy G., Garrett R., Harris S., Chan J., Chen D., Rossini G., Boyce B., Zhao M., and Gutierrez G. Stimulation of bone formation in vitro and in rodents by statins. Science 286 5446 (1999) 1946-1949
27. Okamoto Y., Hidaka S., Yamada Y., Ouchi K., Miyazaki K., and Liu S.Y. Thermal analysis of bones from ovariectomized rats. Journal of Biomedical Materials Research 41 2 (1998) 221-226
28. Pacifici R., Brown C., Puscheck E., Friedrich E., Slatopolsky E., Maggio D., McCracken R., and Avioli L.V. Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proceedings of the National Academy of Sciences of the Unites States of America 88 12 (1991) 5134-5138
29. Perfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., Ott S.M., and Recker R.R. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histrmorphometry Nomenclature Committee. Journal of Bone and Mineral Reseach 2 6 (1987) 595-610
30. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H., Ciliberto G., Rodan G.A., and Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. The EMBO Journal 13 5 (1994) 1189-1196
31. Poole K.E., and Compston J.E. Osteoporosis and its management. BMJ 16 (2007) 1251-1256
32. Ray W.A., Daugherty J.R., and Griffin M.R. Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Injury Prevention 8 4 (2002) 276-279
33. Riggs B.L., and Melton III L.J. The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17 5 (1995) 505S-511S
34. Ruggiero S.L., Mehrotra B., Rosenberg T.J., and Engroff S.L. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review if 63 cases. Journal of Oral and Maxillofacial Surgery 62 5 (2004) 527-534
35. Shi L., Tezuka Y., Subehan, Ueda J., Miyahara T., Yin J., Nobukawa T., and Kadota S. Inhibitory effect of kampo medicines on bone resorption in vitro and preventive effect on bone loss in vivo. Journal of Traditional Medicines 23 (2006) 92-100
36. Sung B., Murakami A., Oyajobi B.O., and Aggarwal B.B. Zerumbone abolishes RANKL-induced NF-kappaB activation, inhibits osteoclastogenesis, and suppresses human breast cancer-induced bone loss inathymic nude mice. Cancer Research 69 4 (2009) 1477-1484
37. Tsuji-Naito K. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation. Bioorganic & Medical Journal 16 20 (2008) 9176-9183
38. Turbi C., Herrero-Beaumont G., Acebes J.C., Torrijos A., Grana J., Miquelez R., Sacristan J., and Marin F. Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: an open-label, prospective, nonrandomized, observational study. Clincal Therapeutics 26 2 (2004) 245-256
39. Wang P.S., Solomon D.H., Mogun H., and Avorn J. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283 24 (2000) 3211-3216
40. Yamada T., Satoh S., Katoh S., Mizuno G., Yoshomura M., and Sakurai I. Pathological analysis on the effects of traditional Chinese drugs in spontaneously hypertensive rats (SHR) aorta. Doumyakukouka 16 (1998) 999-1007
41. Yao X., Chen H., Emura S., Otake N., and Shoumura S. Effects of hPTH (1-34) and Gosha-jinki-gan on the trabecular bone microarchitecture in ovariectomized rat tibia. Okajimas Folia Anatomica Japonica 83 4 (2007) 107-113
42. Yoshie F., Iizuka A., Kubo M., Komatsu Y., Matsumoto A., Itakura H., Takeda. H., Matsumiya T., and Kondo K. Protective effects of saiko-ka-ryu-kotsu-borei-to (Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) against atherisclerosis in Kurosawa and Kusanagi-hypercholesterolemic (KHC) rabbits. Pharmacogical Research 43 5 (2001) 481-488